Correlation Between GlaxoSmithKline PLC and Takeda Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Takeda Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Takeda Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Takeda Pharmaceutical Co, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Takeda Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Takeda Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Takeda Pharmaceutical.
Diversification Opportunities for GlaxoSmithKline PLC and Takeda Pharmaceutical
0.48 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between GlaxoSmithKline and Takeda is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Takeda Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Takeda Pharmaceutical and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Takeda Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Takeda Pharmaceutical has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Takeda Pharmaceutical go up and down completely randomly.
Pair Corralation between GlaxoSmithKline PLC and Takeda Pharmaceutical
Considering the 90-day investment horizon GlaxoSmithKline PLC is expected to generate 10.78 times less return on investment than Takeda Pharmaceutical. But when comparing it to its historical volatility, GlaxoSmithKline PLC ADR is 4.24 times less risky than Takeda Pharmaceutical. It trades about 0.01 of its potential returns per unit of risk. Takeda Pharmaceutical Co is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 2,626 in Takeda Pharmaceutical Co on August 30, 2024 and sell it today you would earn a total of 138.00 from holding Takeda Pharmaceutical Co or generate 5.26% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 82.22% |
| Values | Daily Returns |
GlaxoSmithKline PLC ADR vs. Takeda Pharmaceutical Co
Performance |
| Timeline |
| GlaxoSmithKline PLC ADR |
| Takeda Pharmaceutical |
GlaxoSmithKline PLC and Takeda Pharmaceutical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with GlaxoSmithKline PLC and Takeda Pharmaceutical
The main advantage of trading using opposite GlaxoSmithKline PLC and Takeda Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Takeda Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Takeda Pharmaceutical will offset losses from the drop in Takeda Pharmaceutical's long position.| GlaxoSmithKline PLC vs. Novartis AG ADR | GlaxoSmithKline PLC vs. AstraZeneca PLC ADR | GlaxoSmithKline PLC vs. Roche Holding Ltd | GlaxoSmithKline PLC vs. Bristol Myers Squibb |
| Takeda Pharmaceutical vs. Green Cures Botanical | Takeda Pharmaceutical vs. Cann American Corp | Takeda Pharmaceutical vs. Rimrock Gold Corp | Takeda Pharmaceutical vs. Galexxy Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |